Results 21 to 30 of about 3,668,940 (297)

Cell death in the cardiovascular system [PDF]

Heart, 2006
Cell death is important for both development and tissue homeostasis in the adult. As such, it is tightly controlled and deregulation is associated with diverse pathologies; for example, regulated cell death is involved in vessel remodelling during development or following injury, but deregulated death is implicated in pathologies such as ...
Murray, Clarke, Martin, Bennett, Trevor, Littlewood   +2 more
openaire   +2 more sources

Entosis: The emerging face of non-cell-autonomous type IV programmed death

Biomedical Journal, 2017
The present review summarizes recent experimental evidences about the existence of the non-cell-autonomous death entosis in physiological and pathophysiological contexts, discusses some aspects of this form of cell death, including morphological ...
Isabelle Martins, Syed Qasim Raza, Laurent Voisin, Haithem Dakhli, Frédéric Law, Dorine De Jong, Awatef Allouch, Maxime Thoreau, Catherine Brenner, Eric Deutsch, Jean-Luc Perfettini   +10 more
doaj   +1 more source

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics

, 2022
With the effort and support of the authors, editorial office, and editorial team, the Frontiers in Cardiovascular Medicine, Cardiovascular Therapeutics Section-Research Topic “Insights in Cardiovascular Therapeutics: 2021” has achieved great success and ...
Vazquez-Padron, Roberto I., Yu|, Yang, Xiaofeng, Khan|, Yang|, Khan, Mohsin, Wu, Sheng, Wang|, Snyder, Nathaniel, Wang, Hong, XU, KEMAN, Snyder|, Yu, Jun, Xu|   +13 more
core   +1 more source

A Novel Nomogram Based on a Competing Risk Model Predicting Cardiovascular Death Risk in Patients With Chronic Kidney Disease

Frontiers in Cardiovascular Medicine, 2022
ObjectiveChronic kidney disease (CKD) patients are more likely to die from cardiovascular disease (CVD) than develop renal failure. This study aimed to develop a new nomogram for predicting the risk of cardiovascular death in CKD patients.MethodsThis ...
Ning Li, Jingjing Zhang, Yumeng Xu, Manshu Yu, Guowei Zhou, Yawei Zheng, Enchao Zhou, Weiming He, Wei Sun, Lingdong Xu, Lu Zhang   +10 more
doaj   +1 more source

Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus

Antioxidants, 2023
Subjects with type 2 diabetes mellitus (T2D) are at increased risk for heart failure (HF). The cardiac-specific (FABP3) and adipose-tissue-specific (FABP4) types of the fatty acid binding proteins have been associated with both all-cause and ...
Ricardo Rodríguez-Calvo, Minerva Granado-Casas, Alejandra Pérez-Montes de Oca, María Teresa Julian, Mar Domingo, Pau Codina, Evelyn Santiago-Vacas, Germán Cediel, Josep Julve, Joana Rossell, Lluís Masana, Didac Mauricio, Josep Lupón, Antoni Bayes-Genis, Núria Alonso   +14 more
doaj   +1 more source

Osteoarthritis and cardiovascular death [PDF]

Annals of the Rheumatic Diseases, 2003
Haara et al recently published a study assessing epidemiological aspects of osteoarthritis (OA) in Finland.1 A finding of interest was their identification of OA (in any finger joint) as a predictor of cardiovascular death among men, with the authors suggesting an undetermined metabolic factor as a mechanism. It may be that the …
K A Grindulis, G Bhatia, R Davis, M Sosin, D Connolly, F Khattak   +5 more
openaire   +1 more source

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies [PDF]

, 2011
BACKGROUND: Guidelines differ about the value of assessment of adiposity measures for cardiovascular disease risk prediction when information is available for other risk factors. We studied the separate and combined associations of body-mass index (BMI),
Nordestgaard, Borge G., Stehouwer, Coen; id_orcid, Kaptoge, S., Danesh, J, Wood, Angela M., Thompson, Alex, Sattar, N, Thompson, A, Wormser, D, Emerging Risk Factors Collaboration, Risérus, Ulf,, Salomma, V, Sarwar, N, Danesh, J., Wood, Angela M, Pennells, L, Ärnlöv, Johan,, Woodward, M., Salomaa, Veikko, Sundström, Johan,, Thompson, S.G., Kaptoge, S, Tybjærg-Hansen, Anne, Wormser, D., Ridker, P, Thompson, Simon G, null The Emerging Risk Factors Collaboration, Woodward, Mark, Kizer, Jorge R, Frikke-Schmidt, Ruth, Nordestgaard, BG, Kaptoge, Stephen, Salomaa, V, Lawlor, DA, Eriksson, Henry,, Sarwar, Nadeem, Wood, AM, Kizer, Jorge R., Pennells, Lisa, Stevens, June, Pennells, L., Whitlock, G, Salomaa, V., Nordestgaard, B.G., Collins, Rory, Ridker, Paul, Thompson, A., Lawlor, D.A., Woodward, M, Collins, R, Kizer, J.R., Sattar, N., Lawlor, Debbie A, Sarwar, N., Ingelsson, Erik,, Davey Smith, George, Danesh, John, Stehouwer, Coen, Ridker, P., The Emerging Risk Factors Collaboration,, Di Angelantonio, Emanuele, Wood, A.M., Whitlock, G., Di Angelantonio, E., Sattar, Naveed, Lawlor, Debbie A., Collins, R., Di Angelantonio, E, Kizer, JR, Whitlock, Gary, Thompson, SG, Nordestgaard, Børge G, Stevens, J, Wormser, David, Stevens, J., Thompson, Simon G., Di Angeloantonio, Emanuele, Emerging Risk Factors Collaboration (Döring, A. ; Meisinger, C.)   +77 more
core   +1 more source

Effect of Salt Substitution on Cardiovascular Events and Death [PDF]

New England Journal of Medicine, 2021
Salt substitutes with reduced sodium levels and increased potassium levels have been shown to lower blood pressure, but their effects on cardiovascular and safety outcomes are uncertain.We conducted an open-label, cluster-randomized trial involving persons from 600 villages in rural China.
Neal, B, Wu, Y, Feng, X, Zhang, R, Zhang, Y, Shi, J, Zhang, J, Tian, M, Huang, L, Li, Z, Yu, Y, Zhao, Y, Zhou, B, Sun, J, Liu, Y, Yin, X, Hao, Z, Yu, J, Li, KC, Zhang, X, Duan, P, Wang, F, Ma, B, Shi, W, Tanna, GLD, Stepien, S, Shan, S, Pearson, SA, Li, N, Yan, LL, Labarthe, D, Elliott, P, Di Tanna, Gian Luca   +32 more
openaire   +5 more sources

Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [PDF]

, 2007
BACKGROUND: A recent meta-analysis raised concern regarding an increased risk of myocardial infarction and death from cardiovascular causes associated with rosiglitazone treatment of type 2 diabetes. METHODS: We conducted an unplanned interim analysis of
McMurray, JJV, Beck-Nielsen, H, Jones, Nigel P, Home, PD, Hanefeld, M, Home, Philip D, Gomis, R, Pocock, Stuart J, McMurray, John JV, Beck-Nielsen, Henning, Hanefeld, Markolf, Pocock, SJ, Komajda, M, Jones, NP, Study Group, RECORD, Komajda, Michel, Grp, RS, Gomis, Ramón, RECORD Study Group, McMurray, John J V   +19 more
core   +1 more source

Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and well-controlled LDL-C levels on statins

Frontiers in Cardiovascular Medicine, 2022
BackgroundRecent studies have demonstrated a causal role for elevated triglycerides (TG) in incident cardiovascular (CV) events in patients with established coronary heart disease (CHD) and those with CV risk factors alone, particularly diabetes ...
Sarah Leatherman, Sarah Leatherman, Ryan Ferguson, Ryan Ferguson, Cynthia Hau, Kelly Harrington, Kelly Harrington, Craig Granowitz, Sephy Philip, Peter Paul Toth, Deepak Bhatt, William Boden, William Boden   +12 more
doaj   +1 more source